Celsion Corporation (Celsion) is an oncology drug development company focused on developing drugs for the treatment of various cancer indications. The Company’s product ThermoDox is evaluated in a Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer (RCW). ThermoDox is a liposomal encapsulation of doxorubicin, an oncology drug for the treatment of a range of cancers.
CLSN - Celsion Corporation
Featured Stories on HotStockMarket
post #2 of 23
11/7/10 at 2:33am
post #3 of 23
11/11/10 at 5:11pm
post #4 of 23
11/11/10 at 10:29pm
post #5 of 23
1/5/11 at 3:28pm
post #6 of 23
1/5/11 at 9:09pm
post #7 of 23
1/6/11 at 10:28pm
post #8 of 23
4/28/11 at 10:19am
post #9 of 23
4/28/11 at 11:11am
post #10 of 23
5/2/11 at 6:49am
post #11 of 23
6/5/11 at 11:15pm
post #12 of 23
6/8/11 at 8:20am
post #13 of 23
1/31/12 at 2:37pm
post #14 of 23
6/24/12 at 8:14pm
post #15 of 23
6/25/12 at 2:20pm
post #16 of 23
6/29/12 at 2:46am
post #17 of 23
12/16/12 at 6:35am
post #18 of 23
12/19/12 at 9:47pm
post #19 of 23
1/10/13 at 2:28am
post #20 of 23
1/31/13 at 9:49am
